[1]
Khan, S.A. 2026. Comparative Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Multicenter Propensity-Matched Cohort Study. International Journal of Medical Students. (Aug. 2026).